Author

Stephanie A. Lynch

Observed names: Lynch, Stephanie, S. A. Lynch, S. Lynch, Stephanie Lynch

Institutions: The University of Sydney, Westmead Hospital, Westmead Institute for Medical Research, Western Sydney Local Health District

Observed institutions: Brigham and Women's Hospital, The University of Sydney, La Trobe University, Westmead Hospital, Westmead Institute, Westmead Institute for Medical Research, Dana-Farber Brigham Cancer Center, Western Sydney Local Health District

ORCID: 0000-0002-6141-4093

Observed ORCID: 0000-0002-6141-4093

OpenAlex ID: A5084739109

Phage-Encoded Endolysins

2021 · Fatma Abdelrahman, Maheswaran Easwaran, et al. · Antibiotics · 248

PDF

The Complex Diseases of Staphylococcus pseudintermedius in Canines: Where to Next?

2021 · Stephanie A. Lynch, Karla J. Helbig · Veterinary Sciences · 133

PDF

Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series

2023 · Hadil Onallah, Ronen Hazan, et al. · Med · 57

Therapeutic Phage Monitoring: A Review

2023 · Kiran Bosco, Stephanie Lynch, et al. · Clinical Infectious Diseases · 35

PDF

Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients

2016 · Vishwajith Sridharan, Danielle N. Margalit, et al. · Journal for ImmunoTherapy of Cancer · 19

PDF

Safety and tolerability of bronchoscopic and nebulised administration of bacteriophage

2024 · Jagdev Singh, Stephanie Lynch, et al. · Virus Research · 12

Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy

2023 · Shinwon Lee, Stephanie Lynch, et al. · Infection and Chemotherapy · 12

PDF

Attitudes to phage therapy among Australian infectious diseases physicians

2025 · Martin Plymoth, Stephanie A. Lynch, et al. · International Journal of Antimicrobial Agents · 11

Policy in practice: Cystic Fibrosis Australia and Phage Australia surveys: understanding clinical needs and attitudes towards phage therapy in the cystic fibrosis community

2025 · Stephanie Lynch, Holly Sinclair, et al. · Sustainable Microbiology · 2

PDF

Best Practice Manufacturing and Quality Standards for Bacteriophage Therapy Products: Australian Consensus Statements

2026 · K. Watts, R. CY. Lin, et al. · medRxiv

Characterization and host range associating factors of Staphylococcus aureus bacteriophage PBSA08; Using Australian MRSA reference set

2026 · Shinwon Lee, Stephanie Lynch, et al. · International Journal of Antimicrobial Agents

Cystic Fibrosis Australia and Phage Australia survey: Understanding clinical needs and attitudes towards phage therapy in the CF community

2024 · Stephanie Lynch, Holly Sinclair, et al. · medRxiv

Viability and Infectivity of Bacteriophage PBPA103 After Nebulization With a Vibrating Mesh Nebulizer

2024 · J.A.S. Singh, S. Lynch, et al.

Successful Eradication of Chronic Pseudomonas Aeruginosa Infection in Cystic Fibrosis

2024 · J.A.S. Singh, S. Lynch, et al.

2780. Factors associated with Staphylococcus aureus susceptibility to two lytic bacteriophages; Comparison of phage host susceptibility using a reference set of S. aureus

2023 · Shinwon Lee, Stephanie Lynch, et al. · Open Forum Infectious Diseases

PDF

Effects of fatty acids in bile on the phospholipids of Vibrio cholerae

2017 · Lynch, Stephanie · Texas ScholarWorks (Texas Digital Library)

PDF

Additional file 1: of Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients

2016 · Sridharan, Vishwajith, Margalit, Danielle, et al. · Figshare

Works count: 17

Citation count: 529

H-index: 8

I10-index: 8